Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Frequency and Outcome of Clinically Signficant Incidental Findings in Plasma Cell Dyscrasias Patients Undergoing Whole Body FDG PET-CT Scan

Ehsan Shabbir, MD, Sarah L Mott, Lindsay Dozeman, Umar Farooq, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Guido J. Tricot, MD PhD

Blood (2017) 130 (Supplement 1): 5376.

https://doi.org/10.1182/blood.V130.Suppl_1.5376.5376

Published: 2017

Journal Articles

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Enrico Derenzini, MD PhD, Angela Gueli, MD, Safaa Ramadan, PhD MD, Anna Vanazzi, MD, Simona Sammassimo, MD, Federica Gigli, MD, Niccolo' Frungillo, MD, Riccardo Bruna, MD, Alberto Agazzi, MD, Alberto De Crescenzo, MD, Rocco Pastano, MD, Laura L Travaini, MD, Chiara Grana, MD, Laszlo Daniele, MD, William Arcese, Corrado Tarella, MD

Blood (2016) 128 (22): 3003.

https://doi.org/10.1182/blood.V128.22.3003.3003

Published: 2016

Journal Articles

Transformation of Follicular Lymphoma to a High Grade B-Cell Lymphoma with MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia

David M Aboulafia, MD, Alina Bischin, Russell K. Dorer, MD PhD

Blood (2016) 128 (22): 5421.

https://doi.org/10.1182/blood.V128.22.5421.5421

Published: 2016

Journal Articles

The Predictive Significance of Early Metabolic Remission Post Autologous Hematopoietic Transplantation in Lymphomas Conditioned with Either BEAM or a Busulfan-Based Regimen

Ioanna Sakellari, MD PhD, Despina Mallouri, MD, Varnavas C Constantinou, MD, Michail Iskas, MD, Ioannis Batsis, MD, Stergios Papadimitriou, MDResident, Kira Panteliadou, MDResident, Panayiotis Palladas, MD, Ioannis Datseris, MD PhD, Achilles Anagnostopoulos, MD

Blood (2015) 126 (23): 1984.

https://doi.org/10.1182/blood.V126.23.1984.1984

Published: 2015

Journal Articles

[ 18 F]-Fludarabine Positron Emission Tomography in Chronic Lymphocytic Leukemia Patients: Results of a Phase I Study

Narinée Hovhannisyan, Sylvain P Chantepie, MD, Meziane Ibazizene, Alain Manrique, MD PhD, Oumedaly Reman, MD, Louisa Barre, Michel Leporrier, MD PhD

Blood (2015) 126 (23): 5267.

https://doi.org/10.1182/blood.V126.23.5267.5267

Published: 2015

Journal Articles

The Small Molecule Img-98, a Potent and Selective Inhibitor of the Lysine Demethylase Lsd-1, Effectively Augments the Pro-Differentiation Effects of ATRA in a Pre-Clinical Model of AML

Ronan T. Swords, MDPhDFRCPI FRCPath, Aymee Perez, PhD, Ana Rodriguez, Justin M. Watts, MD, Fernando Vargas, MD, Roy Elias, Hugh Y. Rienhoff, Jr., MD, Arthur Zelent, PhD

Blood (2015) 126 (23): 460.

https://doi.org/10.1182/blood.V126.23.460.460

Published: 2015

Journal Articles

[ 18 F]-Fludarabine Positron Emission Tomography in Diffuse Large B-Cell Lymphoma (DLBCL) Patients: Results of a Phase I Study

Sylvain P Chantepie, MD, Narinée Hovhannisyan, Stéphane Guillouet, Alain Manrique, MD PhD, Oumedaly Reman, MD, Louisa Barre, Michel Leporrier, MD PhD

Blood (2015) 126 (23): 3917.

https://doi.org/10.1182/blood.V126.23.3917.3917

Published: 2015

Journal Articles

Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT

Julien Dubreuil, Roch Houot, MD PhD, Steven Le Gouill, Christiane Mounier, MD, Stéphane Courby, MD, Caroline Dartigeas, MD, Krimo Bouabdallah, MD, Marie Pierre Moles, MD, Alexis Magda, Olivier Tournilhac, MD, Mario Ojeda Uribe, Jean Cyril Bourre, Caroline Bodet-Milin, MD, Jean-Philippe Vuillez, MD PhD, Remy Gressin, MD

Blood (2014) 124 (21): 3070.

https://doi.org/10.1182/blood.V124.21.3070.3070

Published: 2014

Journal Articles

The Role of PET/TC in the Full Range of Monoclonal Gammopathies

Rafael Ríos Tamayo, Juan Sáinz Pérez, Jose Manuel Puerta Puerta, Rosario Leyva Ferrer, Youssef Moatassim de la Torre, Pilar López Garrido, José María de Pablos Gallego, Alvaro Miguel Alba Sosa, Elisa Lopez Fernandez, Lucia Moratalla Lopez, Antonio Romero Aguilar, Manuel Jurado, MD, Jose Manuel Llamas Elvira, Antonio Rodriguez Fernandez, Rocio Sanchez Sanchez

Blood (2014) 124 (21): 3365.

https://doi.org/10.1182/blood.V124.21.3365.3365

Published: 2014

Journal Articles

SUV Max Reduction Criteria of Interim Positron Emission Tomography Improves Prognostic Value in Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Review

Yusuke Okamoto, MD, Shinichi Ochi, MD, Takashi Nagayama, MD, Shogo Nabe, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Hiroyuki Sugiura, MD, Kazuya Okada, MD, Aki Sato, MD PhD, Takayuki Sato, MD PhD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Yasunori Ueda, MD PhD

Blood (2014) 124 (21): 1654.

https://doi.org/10.1182/blood.V124.21.1654.1654

Published: 2014

Journal Articles

FV-162 Is a Novel Orally Bioavailable Proteasome Inhibitor With Improved Pharmacokinetics That Displays Preclinical Efficacy In Vitro and In Vivo

Blood (2013) 122 (21): 1988.

https://doi.org/10.1182/blood.V122.21.1988.1988

Published: 2013

Journal Articles

Pre-Transplant FDG-PET Scan Lacks Prognostic Value in Chemosensitive B-Cell Non-Hodgkin Lymphoma Patients Undergoing Non-Myeloablative Allogeneic Stem Cell Transplantation.

Craig S. Sauter, MD, Hugo Castro-Malaspina, MD, Michael Scordo, MD, Lauren Lechner, Wayne Cohen-Levy, Miguel-Angel Perales, MD, Jenna D Goldberg, MD, Sergio Giralt, MD, Juliet N Barker, MBBS, (Hons), FRACP, Craig H. Moskowitz, MD

Blood (2012) 120 (21): 3130.

https://doi.org/10.1182/blood.V120.21.3130.3130

Published: 2012

Journal Articles

Novel Molecular Imaging Detects Evidence of Altered Bone Marrow Biology in Myeloma Precursor Disease (MGUS and smoldering myeloma): A Prospective Clinical Study

Esther Tan, MD, Liza Lindenberg, MD, Neha Korde, MD, Alexandra Berg, Esther Mena, MD, Baris Turkbey, MD, Omer Aras, MD, Seth M. Steinberg, PhD, Brendan Weiss, MD, Alex Minter, MD, Mary Ann Yancey, RN, Marcia Mulquin, RN, Peter Choyke, MD, Karen Kurdziel, MD, Ola Landgren, MD, PhD

Blood (2011) 118 (21): 2888.

https://doi.org/10.1182/blood.V118.21.2888.2888

Published: 2011

Journal Articles

The Role of Digital Tomosynthesis In the Staging of Newly Diagnosed Multiple Myeloma: Preliminary Data

Nishant de Quadros, M.D., Javier Munoz, M.D., Marnix Van Holsbeeck, M.D., Joseph Craig, MD, Vrushali S. Dabak, MD, Mishal Lala, M.D., Philip Kuriakose, MD

Blood (2010) 116 (21): 4057.

https://doi.org/10.1182/blood.V116.21.4057.4057

Published: 2010

Journal Articles

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging Is a New Sensitive Non-Invasive Method for Staging and Monitoring Chemotherapy Response of Malignant Lymphoma Including Indolent Lymphoma Compared with FDG-PET/CT

Shinji Kishi, MD, PhD, Tatsuro Tsuchida, MD, PhD, Takahiro Yamauchi, MD, PhD, Naoko Hosono, MD, PhD, Satoshi Ikegaya, MD, PhD, Yoshimasa Urasaki, MD, PhD, Hidehiko Okazawa, MD, PhD, Hirohiko Kimura, MD, PhD, Takanori Ueda, MD, PhD

Blood (2010) 116 (21): 4147.

https://doi.org/10.1182/blood.V116.21.4147.4147

Published: 2010

Journal Articles

The Prognostic Value of Residual FDG-Avidity Prior to Allogeneic Stem Cell Transplantation for Lymphoma.

Craig S. Sauter, MD, Juliet N. Barker, MBBS, Andrew D. Zelenetz, MD, PhD, Stephen E. Fleming, MD, Hugo Castro-Malaspina, MD, Craig H. Moskowitz, MD

Blood (2009) 114 (22): 1200.

https://doi.org/10.1182/blood.V114.22.1200.1200

Published: 2009

Journal Articles

Interest and Prognosis Value of Fluorine-18-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography ([ 18 F] FDG-PET/CT) in Aggressive T-Cell Lymphomas

Xavier Cahu, Caroline Bodet-Milin, Thomas Gastinne, Hervé Maisonneuve, Nadine Morineau, Gandhi Damaj, Philippe Solal-Celigny, Philippe Moreau, Henri Jardel, Philippe Moreau, Jean-Luc Harousseau, Françoise Kraeber-Bodéré, Steven Le Gouill, MD, PhD

Blood (2008) 112 (11): 2835.

https://doi.org/10.1182/blood.V112.11.2835.2835

Published: 2008

Journal Articles

Prognosis Value of [ 18 f] FDG-PET Prior Versus after Autologous Stem Cells Transplantation in High Grade Non-Hodgkin’s Lymphoma.

Virginie Roland, Caroline Bodet Milin, Anne Moreau, Thomas Gastinne, Beatrice Mahe, Viviane Dubruille, Hervé Maisonneuve, Nadine Morineau, Philippe Moreau, Henri Jardel, Lucie Planche, Philippe Moreau, Jean- Luc Harousseau, Françoise Kraeber bodere, Steven Le Gouill, MD, PhD

Blood (2008) 112 (11): 2177.

https://doi.org/10.1182/blood.V112.11.2177.2177

Published: 2008

Journal Articles

Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.

Chiara Rusconi, MD, Erika Ravelli, MD, Livio Gargantini, MD, Francesca Ganguzza, MD, Denis Ciapanna, MD, Cristiana Ticca, MD, Mauro Turrini, MD, Gianbattista Bertani, MD, Angelo Vanzulli, MD, Enrica Morra, MD

Blood (2007) 110 (11): 4405.

https://doi.org/10.1182/blood.V110.11.4405.4405

Published: 2007

Journal Articles

FDG-PET in Peripheral T-Cell Lymphoma.

Joanna M. Quigley, BA, Shrinivas Bishu, M.D., Jordan H. Hankins, M.D., James O. Armitage, M.D

Blood (2006) 108 (11): 5499.

https://doi.org/10.1182/blood.V108.11.5499.5499

Published: 2006

NARROW

Frequency and Outcome of Clinically Signficant Incidental Findings in Plasma Cell Dyscrasias Patients Undergoing Whole Body FDG PET-CT Scan

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Transformation of Follicular Lymphoma to a High Grade B-Cell Lymphoma with MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia

The Predictive Significance of Early Metabolic Remission Post Autologous Hematopoietic Transplantation in Lymphomas Conditioned with Either BEAM or a Busulfan-Based Regimen

[ 18 F]-Fludarabine Positron Emission Tomography in Chronic Lymphocytic Leukemia Patients: Results of a Phase I Study

The Small Molecule Img-98, a Potent and Selective Inhibitor of the Lysine Demethylase Lsd-1, Effectively Augments the Pro-Differentiation Effects of ATRA in a Pre-Clinical Model of AML

[ 18 F]-Fludarabine Positron Emission Tomography in Diffuse Large B-Cell Lymphoma (DLBCL) Patients: Results of a Phase I Study

Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT

The Role of PET/TC in the Full Range of Monoclonal Gammopathies

SUV Max Reduction Criteria of Interim Positron Emission Tomography Improves Prognostic Value in Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Review

FV-162 Is a Novel Orally Bioavailable Proteasome Inhibitor With Improved Pharmacokinetics That Displays Preclinical Efficacy In Vitro and In Vivo

Pre-Transplant FDG-PET Scan Lacks Prognostic Value in Chemosensitive B-Cell Non-Hodgkin Lymphoma Patients Undergoing Non-Myeloablative Allogeneic Stem Cell Transplantation.

Novel Molecular Imaging Detects Evidence of Altered Bone Marrow Biology in Myeloma Precursor Disease (MGUS and smoldering myeloma): A Prospective Clinical Study

The Role of Digital Tomosynthesis In the Staging of Newly Diagnosed Multiple Myeloma: Preliminary Data

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging Is a New Sensitive Non-Invasive Method for Staging and Monitoring Chemotherapy Response of Malignant Lymphoma Including Indolent Lymphoma Compared with FDG-PET/CT

The Prognostic Value of Residual FDG-Avidity Prior to Allogeneic Stem Cell Transplantation for Lymphoma.

Interest and Prognosis Value of Fluorine-18-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography ([ 18 F] FDG-PET/CT) in Aggressive T-Cell Lymphomas

Prognosis Value of [ 18 f] FDG-PET Prior Versus after Autologous Stem Cells Transplantation in High Grade Non-Hodgkin’s Lymphoma.

Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.

FDG-PET in Peripheral T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only